Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. HOOD
6. QCOM
7. ACN
8. AZN
9. ROIV
10. AAPL

Go back to Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 13.16 +0.02 (0.15%)
Previous Close $13.14    52 Week High $7.95 
Open $13.15    52 Week Low $0.40 
Day High $13.48    P/E N/A 
Day Low $12.57    EPS $-5.33 
Volume 363,365